A Neurotoxic Snake Venom without Phospholipase A

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

1. Clinical study of anti-snake venom blockade in the treatment of local tissue necrosis caused by Chinese cobra (Naja atra) bites.PLoS neglected tropical diseases · 2022
   Trial
2. Antigenic divergence of cobra short-chain α-neurotoxins: Implications for regional antivenom effectiveness in Southeast Asia.PLoS neglected tropical diseases · 2026
   Article
3. Three finger toxins of elapids: structure, function, clinical applications and its inhibitors.Molecular diversity · 2024
   Review
4. Proteomic Investigation of Cape Cobra (Toxins · 2024
   Article
5. Design and Application of pH-Responsive Liposomes for Site-Specific Delivery of Cytotoxin fromInternational journal of nanomedicine · 2024
   Article
6. Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes.PLoS neglected tropical diseases · 2023
   Article
7. Toxins · 2023
   Article
8. High-throughput proteomics and in vitro functional characterization of the 26 medically most important elapids and vipers from sub-Saharan Africa.GigaScience · 2022
   Article
9. Snake Venomics and Antivenomics of Cape Cobra (Toxins · 2022
   Article
10. Current Insights in the Mechanisms of Cobra Venom Cytotoxins and Their Complexes in Inducing Toxicity: Implications in Antivenom Therapy.Toxins · 2022
    Review
11. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.Toxins · 2022
    Review
12. Equatorial Spitting Cobra (Toxins · 2022
    Article
13. Egyptian cobra (Naja haje haje) venom phospholipase A2: a promising antiviral agent with potent virucidal activity against simian rotavirus and bovine coronavirus.Archives of microbiology · 2022
    Article
14. The myth of cobra venom cytotoxin: More than just direct cytolytic actions.Toxicon: X · 2022
    Article
15. Cytotoxicity of Venoms and Cytotoxins from Asiatic Cobras (Toxins · 2022
    Article
16. Snake Venomics: Fundamentals, Recent Updates, and a Look to the Next Decade.Toxins · 2022
    Review
17. Elucidating the Venom Diversity in Sri Lankan Spectacled Cobra (Toxins · 2021
    Article
18. Snake Venom Proteomics of Samar Cobra (Naja samarensis) from the Southern Philippines: Short Alpha-Neurotoxins as the Dominant Lethal Component Weakly Cross-Neutralized by the Philippine Cobra Antivenom.Frontiers in pharmacology · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as